首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1013篇
  免费   32篇
  国内免费   5篇
耳鼻咽喉   38篇
儿科学   69篇
妇产科学   18篇
基础医学   119篇
口腔科学   22篇
临床医学   148篇
内科学   144篇
皮肤病学   50篇
神经病学   47篇
特种医学   26篇
外科学   110篇
综合类   60篇
预防医学   83篇
眼科学   19篇
药学   71篇
中国医学   12篇
肿瘤学   14篇
  2021年   8篇
  2020年   9篇
  2019年   10篇
  2018年   9篇
  2017年   6篇
  2016年   10篇
  2015年   20篇
  2014年   25篇
  2013年   36篇
  2012年   40篇
  2011年   35篇
  2010年   32篇
  2009年   42篇
  2008年   35篇
  2007年   52篇
  2006年   48篇
  2005年   33篇
  2004年   33篇
  2003年   27篇
  2002年   22篇
  2001年   19篇
  2000年   21篇
  1999年   18篇
  1998年   9篇
  1997年   33篇
  1996年   26篇
  1995年   34篇
  1994年   17篇
  1993年   21篇
  1992年   19篇
  1991年   8篇
  1990年   15篇
  1989年   12篇
  1988年   19篇
  1987年   12篇
  1986年   15篇
  1985年   6篇
  1984年   4篇
  1982年   10篇
  1981年   6篇
  1980年   6篇
  1979年   5篇
  1976年   7篇
  1975年   8篇
  1959年   12篇
  1958年   23篇
  1957年   29篇
  1956年   29篇
  1955年   22篇
  1954年   24篇
排序方式: 共有1050条查询结果,搜索用时 15 毫秒
1.
Fetal B lymphocytes in mice and humans use a limited number of the available VH gene segments. Mouse fetal B cells primarily utilize 3' VH elements, suggesting that the localization of these elements determines their rearrangement frequency. The previously reported non-random usage of human VH genes has been more difficult to explain. In this study the authors analysed the expression of the most proximal 3' human VH element (VH6) using a monoclonal antibody (JE-6). VH6 expression was assessed in various B cell differentiation stages from fetal liver, bone marrow and spleen at 12–20 weeks of gestation. The authors demonstrate that the level of VH6 expression does not exceed a stochastic usage frequency. This suggests that the localization of VH6 does not significantly promote its expression during human fetal life, and that other factors must affect the usage of VH genes during human fetal development.  相似文献   
2.
The usefulness of intra-operative antiemetics and postoperative oral fluid restriction in the prevention of vomiting following anaesthesia for ophthalmic surgery, was studied in 200 patients. They were allocated into four groups of 50 and given either saline (as control), droperidol, metoclopramide or prochlorperazine. Oral intake was restricted postoperatively in half of the patients of each group. Anaesthesia comprised morphine and atropine premedication and a halothane, nitrous oxide and oxygen spontaneous breathing technique. No significant beneficial effects resulted from intra-operative antiemetics; vomiting incidences of 26% after saline and droperidol, 28% after metoclopramide and 14% after prochlorperazine were observed. Younger patients and females vomited most frequently. Restriction of oral fluids did not decrease the incidence of vomiting but demonstrated that approximately half of those patients who vomit do so with their first postoperative oral intake. Vomiting was observed more frequently after non intra-ocular surgery than after intra-ocular surgery (37% cf. 16%, p less than 0.01) and postoperative analgesics were required by more non intra-ocular patients than by intra-ocular patients (25% cf. 5%, p less than 0.001). Squint patients vomited most frequently (48%) and most frequently required postoperative analgesia (35%).  相似文献   
3.
A viscosimetric method was used to investigate the molecular association in aqueous solutions of poly(N-vinyl-2-pyrrolidone), (PVP), of molecular weight 700 000. Limiting viscosity numbers [η] and Huggins constants kH of the polymer solutions were observed to decrease upon addition of denaturing agents such as thiourea and guanidinium sulfate. Guanidinium sulfate was found to be even more effective in its denaturing action as compared to urea and thiourea. The decrease in [η] and kH values increased with increasing concentrations of the denaturing agents. This behaviour was explained on the basis of the rupture of bridges formed by water molecules among different PVP chains, hydrogen bonding being responsible for these intermolecular associations. While no change in the [η] values was observed for PVP in 2 M thiourea solutions upon increasing the temperature from 25°C to 35 and 45°C, for the same increase in temperature the [η] values of aqueous PVP solutions showed substantial decreases. This is also attributed to the breaking of hydrogen bonds existing between PVP molecules.  相似文献   
4.
The pharmacokinetics of 80 mg frusemide given orally were investigated in normal subjects using a direct HPLC method for parent drug and its acyl glucuronide conjugate. Two half-lives could be distinguished in the plasma elimination of both frusemide and its conjugate, with values of 1.25 ± 0.75 and 30.4 ± 11.5 h for frusemide and 1.31 ± 0.60 and 33.2 ± 28.0 h for the conjugate. The renal excretion rate-time profile showed two phases; the rapid elimination phase lasted from 0–15 h and the second and slow phase, from 15–96 h. During the first 15 h, 33.3 ± 4.8% of the dosed frusemide was excreted; in the remaining period 15–96 h, 4.6 ± 1.5% was excreted. In the same two periods the excretion of the glucuronide was 13.4 ± 4.7 and 1.9 ± 1.1%, respectively. The mean renal clearance of frusemide was 90.2 ± 16.9 mL min?1 during the first period and 91.5 ± 29.3 mL min?1 in the remaining period, during which the stimulation of urine production was absent. The renal clearance of the acyl glucuronide was 702 ± 221 mL min?1 in the first period, but only 109 ± 51.0 mL min?1 in the second period. The stimulated urine production in the first 6 h after administration amounted to 2260 ± 755 mL (measured urine production minus baseline value of 1 mL min?1 (360 mL). During the second or rebound period (6–96 h after drug administration), the quantity of urine was 990 ± 294 mL lower than what would have been expected from the baseline production of 5400 mL. This reduced production (0.82 mL min?1) is equivalent to an 18% reduction in the average urine flow rate of 1 mL min?1.  相似文献   
5.
6.
We report the case of a 39-year-old female patient suffering from Sweet's syndrome after an upper respiratory tract infection. Cyclosporin A at a dose of 10 mg/kg per day was given as initial treatment. Skin lesions and general malaise resolved within 9 days. The cyclosporin dose was decreased within 21 days, without recurrence of the eruption. Cyclosporin is a potent inhibitor of T lymphocytes, but affects granulocyte and monocyte functions as well. Success of treatment in our case shows that cyclosporin represents an alternative to steroid treatment in patients with Sweet's syndrome.  相似文献   
7.
A short ACTH test was performed in the six parents, and four siblings, of three cases with 17 alpha-hydroxylase deficiency. Baseline steroid levels were all normal in female heterozygotes but in males 17 alpha-hydroxyprogesterone levels were elevated. After ACTH-stimulation, plasma levels of corticosterone were elevated in five obligate heterozygotes and 18-hydroxydeoxycorticosterone levels were increased in four of them. Two of the four siblings had biochemical signs of heterozygosity. The short ACTH test appears to be an efficient method for detecting heterozygosity, but the abnormalities found are more heterogeneous than previously suggested.  相似文献   
8.
The impact of changes in 1993 of the old 1987 WHO/CDC AIDS casedefinition was studied in a cohort of 153 HIV-infected injectiondrug users (IDUs) and 502 HIV-infected homosexual men in Amsterdam.It appeared that the extension in Europe of the old AIDS definitionto also include recurrent pneumonia, pulmonary tuberculosisand invasive cervical neoplasia, strongly increases the numberof persons diagnosed with AIDS among IDUs, but will hardly influencethe AIDS incidence among homosexual men. As recurrent pneumoniaand pulmonary tuberculosis are present among drug users withhigh CD4 cell counts, the incidence of these diseases may partlybe determined by environmental factors. The extension of theold 1987 AIDS definition in the USA with CD4 count <200 cells/mm3In addition to the 3 above-mentioned diseases, will also havea larger impact on drug users than on homosexual men.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号